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Trauma is one of the most common reasons for hospitalization 
in the emergency department (ED). The majority of patients 
in EDs have fractures, especially long bone fractures, in 
which anxiety and pain are the most frequent symptoms. Both 
symptoms lead to complications such as activation of the 
sympathetic system, mutual endocrine cell system, respiratory 
system (hyperventilation), and central nervous system (fear 
and anxiety), which threaten the patient’s health.[1] In the ED 
patients, pain is the first complaint and presentation which 
should be relieved. In the past, clinicians pointed out that pain 
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relief accounted for more than half of ED visits,[2] although the 
first step is to perform the analgesic treatment. According to the 
previous reports, pain needs to be addressed within 20–25 min 
after arrival at the ED.[3,4] In addition to clinical benefits, pain 
relief has a variety of psychological benefits such as decreased 
tachycardia and reduced blood pressure (BP) and heart rate 
resulting from calmness.[5]
The best pain medication for suitable and quick pain reduction 
should also be taken into account in analgesia methods. Not 
all pain medications are suggested for all patients due to their 
side effects and mechanism of pain relief, and a variety of 
approaches are considered for different parts of the body.[6,7] 
Availability of specific therapies can result in the management 
of analgesic agents. Besides that, route of drug administration 
also has an important role in pain management. For example, 
when pain is severe, intravenous (IV) route is preferable 
because of high accessibility and patients’ satisfaction.[8] 
The newer methods, such as intranasal or oral transmucosal, 
are less known compared with conventional approaches 
such as oral or IV.[9] It has also been reported that the use 
of multiple medications would have adverse effects on the 
pain care. Furthermore, relatively mild side effects may 
be exacerbated when more than one drug is administrated. 
Moreover, co-administration of multiple analgesics leads to 
pharmacokinetic ambiguities, and the selected doses may not 
have a beneficial effect on pain relief.[5]
Nevertheless, there are some exceptions to the above statement; 
for example, the use of ketamine as the opioid-sparing agent 
is beneficial for reducing the overall dose of certain analgesics 
such as morphine.[10] Morphine is one of the most routine 
medications for analgesia in ED, which is prescribed for severe 
acute pain,[11] but some unwanted adverse effects have been 
observed for morphine during analgesia, which is related to the 
titration of morphine during IV injection.[12] In this condition, 
a combination of nonopioid drugs is the best approach to 
reduce the amount of injected morphine (morphine-sparing 
effect), which causes less toxicity and leads to higher patients’ 
satisfaction.[13] The best choice for combination with morphine 
is ketamine, which can block Mg-dependent channel.[14] This 
combination can be efficiently used as a nebulized analgesic 
drug because it prevents the airway reflexes and also few side 
effects have been reported for it.[15] Many studies haverevealed 
that IV concomitant use of ketamine and morphine provides 
better analgesia.[16] The benefits of this combination have 
also been confirmed in both animal studies[17] and human 
subjects.[18]
It should be noted that pain cannot be relieved if it cannot 
be evaluated by assessment methods. The most famous pain 
assessment instrument is visual analog scale (VAS) that 
provides appropriate data about patient’s pain intensity for 
clinicians. In this method, the pain intensity is reported by 
patients using a 10-point simple scale.[19] In this way, clinicians 
can choose the best analgesia approach for reducing the pain 
that consequently leads to higher patients’ satisfaction.[20]
This study was conducted to evaluate the efficacy of nebulized 
ketamine with morphine compared to IV morphine alone 
in patients with traumatic long-bone fractures and also to 
investigate the clinical features of patients before and after 
analgesic administration and their satisfaction with the two 
analgesia methods.
Materials and MethOds
In this clinical trial, the study population consisted of patients 
suffering from traumatic long-bone fractures and complaining 
of severe pain referred to the EDs of Alzahra Hospital and 
Kashani Hospital during 2015–2016. The sample size was 
calculated as 44 patients in each group using a sample size 
formula for comparing the proportion between the two groups 
and with considering the assumption of noninferiority and 
with 95% confidence level, 80% statistical power of test and 
considering that the proportion success rate of pain reduction 
for nebulized ketamine and morphine in previous studies was 
0.524.[21] Furthermore, the rate of noninferiority limit was 
considered 0.3.
The patients who were suffering from traumatic long-bone 
fractures and complaining of severe pain with the VAS pain 
score >7, in the age group of 18–65 years and those who 
consent to participate in the study with the injured limb 
of primarily immobilized by a splint before prescribing 
analgesics were included. The patients with a history of asthma, 
chronic obstructive pulmonary disease and seasonal allergy, 
using inhaler to control respiratory symptoms, sensitivity 
to ketamine, sensitivity to opioids, those with a history of 
cardiovascular disease, psychotic disorder and any trauma to 
the head or who wish to discontinue cooperating in the study 
were excluded.
Then, the patients were randomly allocated into the two groups 
through the randomized block design [11 blocks with a size of 
4 to compose two groups of 44 Figure 1].
The ethics code (no. 395108) was obtained from the Ethics 
Committee of the Research and Technology, Deputy of the 
Isfahan University of Medical Sciences, and also from all 
patients provided a written informed consent form.
Next, we recorded demographic and clinical characteristics of 
the patients, such as sex, age, site of fracture, pain (by VAS), 
BP, oxygen saturation (O2 sat), heart rate, and respiratory 
rate (RR) at baseline.
Then, in one of the groups, to control pain, IV morphine (Darou 
Pakhsh Holding Co., Iran) was injected at the standard 
dose (0.1 mg/kg).
In the second group, nebulized morphine and ketamine by the 
oxygen flow of 5 l/min using a partial rebreathing mask. The 
dose of ketamine (RotexMedica GmbH Co., Trittau, Germany) 
was 1.5 mg/kg and the dose of morphine (Darou Pakhsh 
Holding Co., Iran) was 0.1 mg/kg. If the sedation of patients 
was intensified and progressed from mild-to-moderate toward 
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the establishment of dissociative sedation (characterized by 
profound analgesia and amnesia with retention of protective 
airway reflexes, spontaneous respirations, and cardiopulmonary 
stability),[22,23] or if any other complications and changes in 
BP (arbitrary BP ≥ 180/120 or arterial BP <90 mm Hg or 
mean arterial pressure <65),[24] and life-threatening heart 
rate (ventricular rate <60 beats/min, or >100 beats/min)[25,26] 
occurred, the morphine and ketamine flow was discontinued 
and the patient was excluded from the study.
On the other hand, if no response to pain in the nebulized 
ketamine and morphine group was observed after 15 min, 
IV morphine was used to relieve pain and the patient was 
excluded (in this study, all of the patients reported some relief 
of pain).
Both groups were evaluated at 15 and 30 min after the 
intervention. The data on pain scores (by VAS), BP, heart 
rate and RR, O2 sat, possible side effects, and the patients’ 
satisfaction were collected by someone who was not blind to 
the patient’s group.
Finally, the collected data were analyzed using the SPSS 
(version 20; SPSS Inc., Chicago, Ill., USA). Qualitative data 
in the forms of frequency and frequency percentage and 
quantitative data in the forms of mean and standard deviation 
have been demonstrated. As inferential statistics, respectively, 
Fisher’s exact test and Chi-square test were used to compare 
the frequency distribution of sex and fracture site between 
the two groups while independent t-test was used to compare 
the age between these two groups. Furthermore, the results of 
the Kolmogorov–Smirnov normality test indicated nonnormal 
distribution of the variables; we used the Mann–Whitney test 
to compare the means of continuous variables between the 
two groups and repeat measure analysis test was also used for 
comparing between the two groups in different times. In all 
analyses, we considered the significance level <0.05.
results
In this study, the IV morphine group included 38 men (88.4%) 
and 6 women (13.6%) and the mean age of the patients in this 
group was 31.60 ± 10.75 years. Furthermore, the nebulized 
morphine and ketamine group consisted of 37 men (84.1%) 
and seven women (15.9%) and the mean age of the patients 
in this group was 36.11 ± 12.63 years (P > 0.05). Fractures 
sites were not statistically significantly different in the two 
groups (P = 0.975). In all patients, the injured limb was 
immobilized by the splint in all stages, and thus immobilization 
was performed in both groups [Table 1].
Furthermore, on an average, there was no significant difference 
between the two groups in terms of the percentage of O2, 
systolic BP (SBP), RR and heart rate of patients at baseline. 
Furthermore, they were not significantly different at 15 and 
30 min after treatment (P > 0.05). However, the analysis of 
the repeated measure showed that the impacts of the follow-up 
were not the same in the IV morphine group and nebulized 
morphine and ketamine groups (P < 0.001) [Table 2].
Figure 1: Flowchart consort
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The mean pain scores were not significantly different 
between the two groups at baseline (P = 0.119), but 
15 min after the treatment, the mean pain score in the 
IV morphine group (4.58 ± 1.82) was lower than the 
mean pain score in the nebulized morphine and ketamine 
group (6.75 ± 0.92) (P < 0.001), and 30 min after the 
treatment, pain scores in the two groups were similar. Hence, 
the mean pain score in the two groups significantly decreased 
during the treatment (P < 0.001). Furthermore, the effect 
of the time * group factor in the repeated measure analysis 
showed a significant difference between the two groups 
[P = 0.006 and Table 3].
Furthermore, the pain reduction within 30 min after the 
treatment was not significantly different between the two 
groups with respect to the fracture sites [P > 0.05 and Figure 2].
The adverse effects such as nausea and vomiting were reported 
in three patients (6.8%) in the IV morphine group and in 
one patient (2.3%) in the nebulized morphine and ketamine 
group (P = 0.295); however, other complications such as 
apnea, amnesia, increased salivation, restlessness, nystagmus, 
laryngospasm, and delirium were not observed .
The mean patients’ satisfaction scores in the IV morphine 
and nebulized morphine and ketamine groups were 
1.95 ± 0.58 and 2.07 ± 0.59, respectively, was which 
showed no significant difference using the Mann–Whitney 
test (P = 0.360) [Figure 3].Table 1: Basic and clinical characteristics of patients in 
both groups
Characteristics IV morphine 
group (%)




Male 38 (88.4) 37 (84.1) 0.563
Female 6 (13.6) 7 (15.9)
Age; year 31.60±10.75 36.11±12.63 0.077
Fracture site
Humerus 6 (14) 7 (15.9) 0.975
Radius 6 (14) 7 (15.9)
Femur 11 (25.6) 13 (29.5)
Tibia 6 (14) 6 (13.6)
Ulnar and 
radius
10 (23.3) 7 (15.9)
Tibia and 
fibula
4 (9.3) 4 (9.1)
IV: Intravenous
Figure 2: The bar chart illustrating mean pain relief in two groups in 
terms of fracture site
Table 2: Determination and comparison of clinical factors between the two groups
Variables IV morphine group Nebulized morphine and ketamine group P***
O2 sat at baseline 98.00±1.11 97.98±1.07 0.904
O2 sat after 15 min of treatment 97.72±1.10 97.86±1.17 0.433
O2 sat after 30 min of treatment 97.58±1.26 97.82±1.23 0.404
P time* <0.001
P time × group** <0.001
SBP at baseline 125.81±20.64 125.11±20.50 0.716
SBP after 15 min of treatment 123.30±20.18 125.68±20.48 0.521
SBP after 30 min of treatment 122.49±19.10 127.16±19.33 0.214
P time* 0.127
P time × group** 0.001
RR at baseline 12.84±1.56 12.93±1.60 0.731
RR after 15 min of treatment 12.77±0.95 12.70±1.62 0.609
RR after 30 min of treatment 12.72±0.93 12.70±1.62 0.881
P time* 0.555
P time × group** 0.861
PR at baseline 80.84±5.54 79.93±5.63 0.501
PR after 15 min of treatment 79.49±5.90 79.75±5.60 0.828
PR after 30 min of treatment 79.23±5.99 81.55±5.61 0.091
P time* <0.001
P time × group** 0.001
*Effect of factor of time in repeated measurement analysis, **Effect of factor of time*group in repeated measurement analysis, ***Mann-Whitney U-test 
for comparison between the two groups. O2 sat: Oxygen saturation, RR: Respiratory rate, PR: Pulse rate, SBP: Systolic blood pressure
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The results of Table 2 showed that the hemodynamic changes 
during the study. The effect of time in repeated measures 
analysis of variance showed that changes in the O2 sat and pulse 
rate (PR) were significant. Furthermore, the effect of time × 
group in O2 sat, SBP and pulse rate (PR) was significant, which 
showed that the changes of these outcomes were significant 
between the two groups during the treatment.
discussiOn
The results of this study showed that in patients receiving IV 
morphine, the amount of saturated oxygen was significantly 
decreased after 30 min (P < 0.001), but the trend of decrease 
in the nebulized ketamine and morphine group was not 
statistically significant (P > 0.05).
Furthermore, in the IV morphine group, the decrease in the SBP 
and PR was significant after 30 min; however, both factors in 
the nebulized group were increased significantly. However, in 
general, the trend of clinical factors between the two groups 
was not statistically significant (P > 0.05).
Administration of ketamine has been reported to be in the 
relationship with decreased resistance to the opioid drugs such 
as morphine in rats.[27-30] Moreover, ketamine could.
In addition, the mean of VAS at the baseline was similar in 
both groups, but after 15 min of pain treatment, the significant 
decrease in the IV group was seen in comparison with 
nebulized patients (P < 0.001), and after 30 min, the mean of 
VAS within both groups was similar again (P = 0.508). On the 
other hand, the mean of VAS from baseline up to 30 min was 
significantly decreased in each group (P < 0.001). Therefore, 
it could be said that IV morphine is more successful on early 
pain management than nebulized morphine with ketamine; 
however, in the long term (30 min), the influence of the two 
methods in the controlling and reduction of pain is the same. 
However, if the purpose of treatment is quick treatment with the 
least complications and no significant decrease in the amount 
of saturated oxygen, nebulized morphine and ketamine would 
be a better approach. In addition, the level of the patient’s 
satisfaction was the same in the two groups.
Gurnani et al. found that in the ketamine and morphine 
group, the intensity of analgesia was more than in the IV 
morphine alone users, and patients in the ketamine group did 
not require the supplemental analgesia administration after 
initial analgesic drug administration.[31] Moreover, Weinbroum 
concluded that administration of small dose of ketamine with 
morphine was significantly more beneficial than use of IV 
morphine after 30 min in terms of pain reduction intensity 
and patient’s satisfaction.[32] This issue is due to having more 
half-life of nebulize ketamine compared with IV ketamine 
and morphine and therefore, the efficacy of nebulization is 
more, in terms of the duration.[33] Furthermore, it has been 
stated that ketamine inhalation can significantly reduce various 
inflammatory responses, and circulatory parameter, such as 
BP, the central venous pressure, tidal volume, and fraction 
of inspired oxygen (FIO2) were improved better compared to 
ketamine infusion.[34]
However, at the ED, use of morphine is so popular with 
relatively few reported risk factors and we did not aim to tell 
that we should stop using morphine, because according to 
broad studies about the beneficial effects of IV morphine in 
abrupt pain relief in emergency situation, such as trauma, and 
necessity of pain reduction in ED patients as soon as possible, 
we believe that the limited dose of using morphine in adult 
patients nowadays has been resulted in providing inadequate 
analgesia,[35] unwanted side effects for administration of 
morphine in IV route,[5] and the risk of dependency of patients; 
we have to change the route of analgesia, and also regarding to 
patient’s preference for nebulized route, because of difficult IV 
access in some circumstances such as adverse psychological 
aspects or in shock or among drug users that vascular access 
are not available, it would be a beneficial possible alternate 
route which has several advantages, including less sedation 
compared with IV route,[36] alternate route due to the limited 
access for IV intervention,[37] and better absorption of drugs in 
the airway approaches.[38,39] However, it should be noted that 
we did not observe dissociative sedation by nebulized ketamine 
with morphine. On the other hand, limitation of morphine 
dose encourages physicians to use co-administration of safe 
analgesia drugs for ED patients, in especial ketamine, which 
leads to maintenance of stable hemodynamics and reduction 
Figure 3: The bar chart illustrating frequency percentage of patient’s 
satisfaction scores in two groups
Table 3: Determination and comparison of mean pain 
scores between two groups





VAS at baseline 9.63±0.62 9.43±0.57 0.119
VAS after 15 min of 
treatment
4.58±1.82 6.75±0.92 <0.001




P time × group** <0.001
- 0.016
*The effect time factor in repeated measurement analysis, **The effect of 
time×group factor in repeated measurement analysis, ***Mann-Whitney 
U-test for comparison between the two groups. VAS: Visual analog scale, 
IV: Intravenous
Azizkhani, et al.: Efficacy of nebulized ketamine with morphine and intravenous morphine in pain reduction
Archives of Trauma Research ¦ Volume 7 ¦ Issue 3 ¦ July-September 2018 119
of the morphine side effects as an opioid (morphine-sparing 
effect).[40] We believe that the noninvasive nebulized method 
could be a promising approach in near future if larger studies 
with various dosages and longer intervention time perform.
At the end, considering patient’s satisfaction levels and 
according to the fact that drug complication in the IV was 
more than that in the nebulized method and also according 
to the advanced trauma life support guideline for trauma 
patients,[41] it has been stated that all the trauma patients should 
receive the oxygen. We suggest that at the primary survey, 
if life-threatening situations are not observed, the nebulized 
ketamine and morphine could be prescribed with oxygen flow. 
The subsequent studies can be performed to assess the efficacy 
of nebulized ketamine (without morphine) in pain relief of 
traumatic patient.
cOnclusiOn
According to the results of this study, although the use of IV 
morphine has a faster effect on patient’s pain reduction in 
a maximum of 15 min, the use of nebulized morphine and 
ketamine does not reduce BP and heart rate of patients, and 
on the other hand, in the long time of maximum 30 min after 
administration, it has similar effect in controlling and reducing 
the pain and patient’s satisfaction with this method is more 
than the IV morphine. Furthermore, it seems that nebulized 
morphine and ketamine can be more effective in reducing the 
pain in patients with long bone fracture trauma in the long time.
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